PC5 - Pharmacometrics's strategic impact in Drug Development

Moderator(s)

• 

  Bill Denney, PhD (he/him/his)

  CEO
  Human Predictions, LLC

  PDF Slides

Presentations:

• 1:00 PM - 1:15 PM MDT

  Making MIDD Business as Usual: A Strategic Imperative for R&D
  

  Speaker: Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer
• 1:15 PM - 1:30 PM MDT

  Harnessing the Power of Pharmacometrics: Shaping Organizational Strategy to Accelerate Drug Development
  

  Speaker: Mahesh N. Samtani, PhD (he/him/his) – Johnson & Johnson Innovative Medicine